---
title: 'Manager, Medical Operations, EU West at BridgeBio Pharma'
canonical: 'https://feeny.ai/job/manager-medical-operations-eu-west-bridgebio-pharma-paris-b8v0setzs58a'
type: 'job'
last_seen: '2026-10-21'
---

# Manager, Medical Operations, EU West at BridgeBio Pharma

- **Company:** BridgeBio Pharma
- **Location:** Paris, France
- **Posted:** 2026-10-15
- **Last confirmed live:** 2026-10-21
- **Apply:** https://job-boards.greenhouse.io/bridgebio/jobs/5265684007

## Job description

Mavericks Wanted

When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on

In 2015, we pioneered a “moneyball for biotech” approach, pooling projects and promising early-stage research from academia together under one financial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way. We build bridges to groundbreaking advancements in rare disease, and develop life-changing medicines for patients with unmet needs as fast as humanly possible.

Together we define white space, push boundaries, and empower people to solve problems. If you're someone who defies convention, join us and work alongside some of the most respected minds in the industry. Together, we'll ask "why not?" and help reengineer the future of biopharma. At BridgeBio, we value curiosity and experimentation—including the ethical & thoughtful use of AI to improve clarity, speed, and quality of work.

## What You'll Do

As Medical Operations Manager, EU West, you will report to the Medical Director EU West and partner closely with the Medical Advisor EU West to build the operating backbone for the affiliate's three rare-disease launches in achondroplasia, limb-girdle muscular dystrophy, and genetic hypocalcaemia. You will own the planning, logistics, systems, and financial coordination of Medical Affairs activities and coordinate local regulatory, compliance, and LEA (loi d’encadrement des avantages) workflows so that execution is efficient, documented, auditable, and aligned with BridgeBio standards and French requirements. The main focus of this role will be France.

## Responsibilities

- Medical operations planning: Translate the France medical strategy into an integrated operational plan, activity calendar, RACI, budget, milestones, risks, and KPI dashboard across the three portfolio programs
- Activity and event delivery: Manage end-to-end operations for advisory boards, scientific meetings, congresses, medical education, internal training, and field initiatives, including invitations, contracting, fair-market-value checks, travel, venues, purchase orders, invoices, and close-out documentation
- Regulatory coordination: Serve as the affiliate operational contact for Regulatory Affairs, coordinating local inputs, translations, document readiness, correspondence, regulatory intelligence, product information, and launch-readiness actions with regional or global teams and external partners. Support early or compassionate access workstreams when applicable
- Compliance and LEA governance: Coordinate activities under the French Law on the Regulation of Benefits (Loi d'Encadrement des Avantages, LEA), including the applicable declaration or authorization workflows for healthcare professional, healthcare organization, patient, and patient-organization engagements; maintain approval evidence, due-diligence records, contracts, and auditable files in partnership with Legal and Compliance
- French transparency requirements: Support accurate and timely capture, reconciliation, and submission of reportable agreements, remuneration, and benefits in line with French transparency and anti-benefit requirements and applicable industry standards
- Medical review operations: Administer the review and approval workflow for scientific, educational, and cross-functional materials, including intake, routing, version control, source documentation, expiry management, and compliant archiving
- External funding and research operations: Coordinate medical grants, sponsorships, donations, investigator-sponsored research, collaborative projects, and other external requests from intake through review, contracting, payment, milestone tracking, and close-out
- Data privacy and records: Embed privacy-by-design and appropriate consent, retention, access, and data-handling practices into medical activities, particularly for health data, research, surveys, and stakeholder databases, in collaboration with the Data Protection Officer and relevant experts
- Budget and vendor management: Own Medical Affairs budget tracking and forecasting; manage vendor sourcing, onboarding, contracts, purchase orders, invoices, service levels, and performance reviews in coordination with Finance and Procurement
- Systems and reporting: Maintain fit-for-purpose Medical Affairs systems and repositories, including CRM and insight workflows, approval platforms, activity trackers, congress calendars, contact records, dashboards, and document libraries; drive data quality and user adoption
- SOPs training and audit readiness: Maintain local procedures, work instructions, training matrices, and evidence of completion; support monitoring, audits, inspections, deviations, and corrective and preventive actions
- Launch readiness and cross-functional delivery: Maintain the medical launch-readiness tracker and coordinate dependencies with Medical, Regulatory, Market Access, Pharmacovigilance, Commercial, Patient Advocacy, Finance, Legal, Compliance, and regional or global colleagues
- Safety and quality routing: Ensure operational pathways are in place for timely escalation of adverse events, product complaints, and medical information requests, and that vendors and team members complete required training

Where You'll Work

- This is a France-based role with the Paris area as the designated office location
- Regular travel across France is expected, with periodic travel to the International Headquarters in Zug, Switzerland, and to other countries in the Europe West region

## Who You Are

- PhD, PharmD, Bachelor's or Master's degree in life sciences, pharmacy, business, project management, or a related discipline
- At least 2-5 years of Medical Affairs operations, commercial operations, regulatory operations, compliance operations, or comparable experience in the pharmaceutical or biotechnology industry
- Hands-on experience delivering healthcare professional engagements, congresses, advisory boards, grants, sponsorships, or externally sponsored research in France
- Working knowledge of French transparency, anti-benefit, data-protection, contracting, and record-retention requirements relevant to life-sciences activities
- Experience coordinating regulatory or launch-readiness deliverables with regional or global teams and external partners
- Strong budget, procurement, vendor, contract, timeline, and risk-management capabilities
- Proficiency with Microsoft 365 and experience with CRM, content approval, or document-management systems; ability to learn new platforms quickly
- Fluent French and professional English, both written and spoken

Strongly Preferred

- Experience in Medical Affairs operations for rare diseases or specialty medicines, including at least one pre-launch or launch
- Experience in a small biotechnology affiliate, a new country organization, or another resource-constrained environment requiring hands-on execution
- Practical experience with LEA workflows, transparency reporting, medical review systems, early access operations, or French regulatory coordination
- Project-management or process-improvement certification

Expected Attributes

- Operate independently and quickly, with a strong sense of ownership
- Exceptional organization, attention to detail, and follow-through
- A practical compliance mindset and the confidence to raise risks early
- Ability to prioritize across products, stakeholders, and geographies
- Calm, service-oriented collaboration under tight deadlines
- Direct and clear communication in both French and English

As a global company, our comprehensive benefits may vary based on location.  We have high expectations for our team members. We make sure those working hard for patients are rewarded and cared for in return.

For BridgeBio Full-Time U.S Based Roles:

Financial & Rewards

- Market-leading compensation
- 401(k) with employer match
- Employee Stock Purchase Program (ESPP)
- Pre-tax commuter benefits (transit and parking)
- Referral bonus for hired candidates
- Subsidized lunch and parking on in-office days

Health & Well-Being

- 100% employer-paid medical, dental, and vision premiums for you and your dependents
- Health Savings Account (HSA) with annual employer contributions, plus Flexible Spending Accounts (FSA)
- Fertility & family-forming benefits
- Expanded mental health support (therapy and coaching resources)
- Hybrid work model with flexibility
- Flexible, “take-what-you-need” paid time off and company-paid holidays
- Comprehensive paid medical and parental leave to care for yourself and your family

Skill Development & Career Paths:

- People are part of our growth and success story - from discovery to active drug trials and FDA pipelines, there are endless opportunities for skill development and internal mobility
- We provide career pathing through regular feedback, continuous education and professional development programs via LinkedIn Learning, LifeLabs, & BetterUp Coaching
- We celebrate strong performance with financial rewards, peer-to-peer recognition, and growth opportunities

By applying, you acknowledge that BridgeBio will process your personal information as described in our [Global Candidate Privacy Notice](https://bridgebio.com/bridgebio-global-candidate-privacy-notice). Questions or requests: dataprivacy@bridgebio.com

## About BridgeBio Pharma

## Company Overview
- **One-liner**: BridgeBio Pharma develops transformative medicines for genetic conditions, using a decentralized hub-and-spoke model to accelerate drug development from early research to commercialization.
- **Entity Type**: Public (Nasdaq: BBIO)
- **Headquarters**: Palo Alto, California, USA (with hybrid offices in San Francisco, CA)
- **Founded**: Not explicitly stated in provided sources; the company references “over the past 10 years” as of 2026, suggesting founding around 2015–2016.
- **Founders**: Not publicly available from provided sources.

## Core Business
- **Primary industry**: Biotechnology / Genetic disease therapeutics
- **Target customers**: Patients living with genetic conditions, healthcare providers, payers, and academic research partners
- **Mission**: “To develop transformative medicines for genetic conditions” and “bridge the gap between advancements in genetic science and meaningful medicines for underserved patient populations.”

## Products & Services
BridgeBio’s pipeline includes both approved therapies and investigational candidates across dozens of indications. Key offerings:

- **Acoramidis**: Approved for transthyretin amyloidosis (ATTR) – a first-in-class treatment with $8B+ peak year sales potential.
- **Infigratinib**: Phase 3 completed for achondroplasia; published in the *New England Journal of Medicine* (2026).
- **BBP-418**: Investigational for Limb-Girdle Muscular Dystrophy Type 2I/R9 (LGMD2I/R9).
- **Encaleret**: Investigational for Autosomal Dominant Hypocalcemia Type 1 (ADH1).
- **BBP-812**: Investigational for Canavan Disease.
- **BridgeBio Oncology Therapeutics (BBOT)**: Subsidiary focused on RAS and PI3Kα-driven cancers.
- **GondolaBio**: Subsidiary developing bioavailable small molecule inhibitors for oncology.
- **Other programs**: Covering hypochondroplasia, chronic hypoparathyroidism, and more.

The company has received **3 FDA approvals** and has over **70+ peer-reviewed publications**.

## Market Standing
- **Valuation / Market Cap**: Not explicitly stated in provided data; as a public company, current market cap can be found on financial platforms (e.g., ~$8B based on peak sales potential, but not a direct valuation number).
- **Key Metric**: **3 FDA-approved medicines**; **2000+ patients enrolled** in global clinical trials; **6 Phase 3 trials** conducted over the past 10 years.
- **Notable Investors / Partners**: Not detailed in provided sources, but the company partners with leading academic institutions to advance early-stage research.
- **Growth Signals**: Recent publication of Phase 3 PROPEL 3 trial results in NEJM (June 2026); expansion into oncology via BBOT and GondolaBio; 100% of pipeline is first-in-class or best-in-class; 48 unique disease indications targeted.

## Competitive Advantages
- **Hub-and-spoke model**: Decentralized structure where autonomous affiliate teams (spokes) focus on specific conditions, while a central hub provides clinical, regulatory, and commercial expertise. This enables speed, scalability, and risk reduction.
- **First-in-class / best-in-class focus**: 100% of pipeline aims to be first or best in class, targeting underserved genetic conditions with clear biological rationale.
- **Speed and adaptability**: The model allows rapid pivoting to the most promising opportunities, reducing development timelines compared to traditional biotech.
- **Strong scientific foundation**: Over 70 peer-reviewed papers and collaborations with top academic institutions.

## Strategic Focus
- **Advance late-stage pipeline**: Prioritize Phase 3 programs (e.g., infigratinib for achondroplasia, acoramidis for ATTR) and seek additional FDA approvals.
- **Expand into oncology**: Leverage subsidiaries BBOT and GondolaBio to address RAS/PI3Kα-driven cancers.
- **Maintain urgency**: “Every minute counts” – continue to operate with speed and autonomy to bring treatments to patients faster.
- **Build on commercial success**: Leverage existing approved products to fund further R&D and expand global reach.

## Why Work Here
- **Award-winning culture**: Named **#1 Best Place to Work** by BioSpace (2026, small biotech category) with an **88% employee engagement score** in 2025.
- **Flexible work model**: Hybrid policy with offices in San Francisco and Palo Alto, CA; “flexible working model” emphasized.
- **Compensation and benefits**: Market-leading pay, comprehensive healthcare, and strong emphasis on growth and internal mobility.
- **Impact-driven mission**: Work on transformative treatments for genetic conditions where patient need is urgent – “Impatient for Patients” is a core mantra.
- **Values**: Put patients first, let science speak, think independently, speak up, and act with urgency. The culture is described as “high on standards, low on convention.”
- **Growth opportunities**: 113 open jobs (as of mid-2026) across functions including clinical, regulatory, manufacturing, commercial, and corporate; talent community available for future roles.

## Sources
1. [bridgebio.com](https://bridgebio.com/) – Home page with pipeline overview and $8B peak sales potential
2. [bridgebio.com/about](https://bridgebio.com/about) – Company description, hub-and-spoke model, and key metrics
3. [bridgebio.com/careers](https://bridgebio.com/careers) – Careers page with awards, culture, and benefits
4. [investor.bridgebio.com](https://investor.bridgebio.com/overview/default.aspx) – Investor relations overview, latest news, and corporate presentation
5. [job-boards.greenhouse.io/bridgebio](http://job-boards.greenhouse.io/bridgebio) – Current job listings (113 roles) and departmental categories

## Other roles at BridgeBio Pharma

- [Commercial Learning & Development, Associate Director](https://feeny.ai/job/commercial-learning-development-associate-director-bridgebio-pharma-san-trqgav8a5c7b) — San Francisco, CA
- [Principal Clinical Database Systems Programmer](https://feeny.ai/job/principal-clinical-database-systems-programmer-bridgebio-pharma-united-states-q01smtxf9bc3) — United States
- [Field Reimbursement Manager - Northern CA](https://feeny.ai/job/field-reimbursement-manager-northern-ca-bridgebio-pharma-united-states-th5wwrdfe4n0) — United States
- [Senior Director, Commercial, EU Center](https://feeny.ai/job/senior-director-commercial-eu-center-bridgebio-pharma-germany-4t6tncfrnpf0) — Germany
- [Field Reimburesement Manager - Pennsylvania](https://feeny.ai/job/field-reimburesement-manager-pennsylvania-bridgebio-pharma-united-states-h2c4mn5nf8fg) — United States
- [Field Reimbursement Manager - Michigan](https://feeny.ai/job/field-reimbursement-manager-michigan-bridgebio-pharma-united-states-6shtx6w6zc4w) — United States
- [Senior Manager, Medical Affairs Operations](https://feeny.ai/job/senior-manager-medical-affairs-operations-bridgebio-pharma-san-francisco-t05gjew4g5xx) — San Francisco, CA
- [Sr. Manager/Associate Director, Medical Affairs](https://feeny.ai/job/sr-manager-associate-director-medical-affairs-bridgebio-pharma-united-states-52dejpfy2e92) — United States
- [Field Reimbursement Manager-Southeast](https://feeny.ai/job/field-reimbursement-manager-southeast-bridgebio-pharma-united-states-9r2cmwtagmzc) — United States
- [Field Reimbursement Manager-Pacific](https://feeny.ai/job/field-reimbursement-manager-pacific-bridgebio-pharma-united-states-rzn1q25j1qes) — United States